Qilu Pharmaceutical Co., Ltd.

This study tests whether a daily pill called relugolix can safely reduce heavy menstrual bleeding in women with uterine fibroids. About 120 premenopausal women will receive either the drug or a placebo for several weeks. The main goal is to see if bleeding drops to a normal level…

This study tests a new drug called ESG401 against standard chemotherapy for people with advanced triple-negative breast cancer that cannot be removed by surgery or has spread. About 504 participants will receive either ESG401 or a chemotherapy chosen by their doctor. The goal is …

This early-stage study tests a new drug called QLS-1304 in 180 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. Researchers will also monitor side effects and how the dr…

This study tests a new drug called QLS32015 against two standard treatments (pomalidomide with dexamethasone, or selinexor with dexamethasone) in people whose multiple myeloma has returned or stopped responding to prior therapy. About 228 adults aged 18 and older will be randomly…

This study tests a new antibiotic combination (meropenem and pralurbactam) against a standard treatment for serious pneumonia caught in the hospital or from a breathing machine. About 420 adults aged 18-80 will take part. The goal is to see if the new drug works as well and is sa…

This study tests two experimental drugs, QLP2117 and QL2107, given together to people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and can shrink or control the tumors. About 149 adults will take par…

This study tests a new drug called QLC5508, given together with other anti-cancer medicines, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. About 444 adul…

This study tests whether adding the experimental drug QLS31905 to standard chemotherapy helps people with a specific type of advanced pancreatic cancer live longer. About 602 adults whose tumors have a protein called CLDN18.2 will receive either the drug combo or a placebo plus c…

This study tests a new drug called QLC5508 against standard chemotherapy for people with advanced esophageal cancer that has gotten worse after previous treatments. About 466 adults will be randomly assigned to receive either QLC5508 or a chemotherapy chosen by their doctor. The …

This study tests a new drug called QLS1304 combined with standard hormone therapy for people with advanced ER+/HER2- breast cancer that has stopped responding to hormone therapy alone. The goal is to find the safest and most effective dose and see if the combination can shrink tu…

This study tests several combinations of the experimental drug QLS32015 with other medicines in 160 people whose multiple myeloma has returned or not responded to prior treatment. The goal is to see if these combos can shrink tumors or make cancer undetectable. Participants will …

This early-phase study tests an experimental drug called QLS2309 in about 186 adults with CD70-positive blood cancers that have returned or not responded to standard therapy. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Parti…

This study tests a new drug called QL1706 given before surgery for people with a specific type of colon cancer (MSI-H/dMMR) that has not spread too far. About 363 participants will either get QL1706 or standard treatment. The goal is to see if QL1706 can make the tumor disappear …

This study tests an experimental drug called QL0911 for cancer patients whose platelet levels drop too low after chemotherapy. Low platelets can delay treatment and cause bleeding risks. The trial will compare the drug to a placebo in 235 adults aged 18-75 to see if it safely rai…

This early-stage study is testing how much of the antibiotic combination meropenem-pralubactam gets into the lungs of 16 healthy adults in China. Participants will receive four doses of the drug, and researchers will measure its levels in blood and lung fluids. The goal is to und…